Promotes improved skin tightness & texture FEATURE 3
Clinical evaluation report shows patients are highly satisfied with Lanluma PLLA treatment Non-inferiority trial results: Lanluma garners higher patient satisfaction than PLLA-SCA
Lanluma V is equivalent to PLLA-SCA in reducing wrinkle severity 1
Mean WSRS
% of pa tie nts with ≥1 point scor e d e cr e a se
0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 2
0 10 20 30 40 50 60 70 80 90 100
90.77
1.74
87.69
1.71
Lanluma V (n=65)
PLLA-SCA (n=65)
Lanluma V (n=57)
PLLA-SCA (n=59)
There was no significant difference in the WSRS after week 48 between Lanluma V and PLLA-SCA
The proportion of subjects with <-1 WSRS improvement at week 48 compared with baseline was not statistically significant
WSRS, Wrinkle Severity Rating Scale 1. Clinical Trial Report GN-CIR-01, version 1.0_20190104.
Features Before & After Results 1 2 3 Why Lanluma 3
Product Summary
Training Resources
Mode of Action
Clinical Data
Safety
MaiLi
Lanluma Ellansé Lanluma
PRODUCT COMPARISON
8
Made with FlippingBook Digital Publishing Software